Bokf Na Increases Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Bokf Na boosted its position in HCA Healthcare, Inc. (NYSE:HCA) by 3.3% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,541 shares of the company’s stock after purchasing an additional 144 shares during the period. Bokf Na’s holdings in HCA Healthcare were worth $1,499,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Atlantic Edge Private Wealth Management LLC purchased a new position in shares of HCA Healthcare during the 4th quarter valued at about $27,000. LifeSteps Financial Inc. purchased a new position in shares of HCA Healthcare during the 1st quarter valued at about $33,000. Rise Advisors LLC purchased a new position in shares of HCA Healthcare during the 1st quarter valued at about $36,000. Northwest Investment Counselors LLC purchased a new position in shares of HCA Healthcare during the 1st quarter valued at about $36,000. Finally, Activest Wealth Management purchased a new position in shares of HCA Healthcare during the 1st quarter valued at about $40,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Stock Up 0.6 %

Shares of HCA stock traded up $1.99 during mid-day trading on Friday, hitting $354.78. The stock had a trading volume of 1,215,941 shares, compared to its average volume of 1,679,664. HCA Healthcare, Inc. has a 12-month low of $215.96 and a 12-month high of $356.30. The firm has a market capitalization of $92.92 billion, a P/E ratio of 17.69, a price-to-earnings-growth ratio of 1.35 and a beta of 1.68. The firm’s 50-day moving average is $330.12 and its two-hundred day moving average is $323.11. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 1.02.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping the consensus estimate of $4.97 by $0.53. The firm had revenue of $17.49 billion during the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The business’s revenue for the quarter was up 10.3% compared to the same quarter last year. During the same period in the previous year, the company posted $4.29 EPS. On average, analysts predict that HCA Healthcare, Inc. will post 22.43 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be given a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 0.74%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s payout ratio is 13.16%.

Analysts Set New Price Targets

Several brokerages recently issued reports on HCA. SVB Leerink lifted their target price on HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research note on Wednesday. Deutsche Bank Aktiengesellschaft lifted their target price on HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a research note on Friday, June 28th. Robert W. Baird began coverage on HCA Healthcare in a research note on Thursday, May 30th. They set an “outperform” rating and a $396.00 target price on the stock. JPMorgan Chase & Co. lifted their target price on HCA Healthcare from $327.00 to $332.00 and gave the company a “neutral” rating in a research note on Thursday, May 30th. Finally, Royal Bank of Canada lifted their price objective on HCA Healthcare from $329.00 to $378.00 and gave the stock an “outperform” rating in a research note on Wednesday. Four analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $339.72.

Insider Transactions at HCA Healthcare

In related news, SVP Kathryn A. Torres sold 1,863 shares of the company’s stock in a transaction dated Wednesday, May 15th. The stock was sold at an average price of $326.18, for a total transaction of $607,673.34. Following the transaction, the senior vice president now directly owns 19,612 shares of the company’s stock, valued at approximately $6,397,042.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other news, SVP Kathryn A. Torres sold 973 shares of the stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $312.00, for a total value of $303,576.00. Following the transaction, the senior vice president now directly owns 22,365 shares of the company’s stock, valued at $6,977,880. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Kathryn A. Torres sold 1,863 shares of the stock in a transaction dated Wednesday, May 15th. The shares were sold at an average price of $326.18, for a total value of $607,673.34. Following the completion of the transaction, the senior vice president now directly owns 19,612 shares in the company, valued at $6,397,042.16. The disclosure for this sale can be found here. In the last three months, insiders sold 12,397 shares of company stock valued at $3,921,929. Corporate insiders own 1.60% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.